PT481 – Kanna: The History, Science, and Potential of an Emerging...

Pα+ Psychedelic Bulletin #154: Public & Industry Respond to DEA’s Renewed...

Ensuring the Affordable Becomes Accessible – Lessons from Ketamine’s Antidepressant Development...

European Union Grants €6.5M for Multi-Site Psilocybin Study in Palliative Patients

PT480 – Psychedelics and Consent: Power Dynamics, Boundaries, and the Concept...

The Psychedelic News Feed: Dec 11 2023 – Jan 7, 2024

Psychedelics M&A and Partnerships in 2023

PT479 – Psilocybin in the Midwest and the Need for Potency...

Psychedelic Funding & Public Markets in 2023

Pα+: Knowledge Gaps in Psychedelic Medicalisation, According to ECNP and Regulators

Load more